alpha-Synuclein and intracellular trafficking: impact on the spreading of Parkinson's disease pathology

被引:51
|
作者
Eisbach, Sibylle E. [1 ]
Outeiro, Tiago F. [1 ]
机构
[1] Univ Med Ctr Gottingen, Ctr Nanoscale Microscopy & Mol Physiol Brain, Dept Neurodegenerat & Restorat Res, D-37073 Gottingen, Germany
来源
JOURNAL OF MOLECULAR MEDICINE-JMM | 2013年 / 91卷 / 06期
关键词
alpha-Synuclein; Trafficking; Spreading; Prion; Transmission; Parkinson's disease; TO-NEURON TRANSMISSION; N-TERMINAL ACETYLATION; SUBSTANTIA-NIGRA; RAB GTPASES; SYNAPTIC DYSFUNCTION; AXONAL-TRANSPORT; IRON CONTENT; CELL-DEATH; IN-VITRO; MEMBRANE;
D O I
10.1007/s00109-013-1038-9
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Parkinson's disease is characterized by intracellular proteinaceous depositions known as Lewy bodies. These largely consist of the protein alpha-synuclein, whose physiological function remains unclear, but mutations and overexpression of the protein have been shown to cause early onset cases of Parkinson's disease. Deregulation of alpha-synuclein biology causes neurodegeneration and impaired neuronal trafficking, hinting at a possible contribution to the pathological mechanism. Recent studies produced some evidence hinting at the involvement of several regulators of the transport machinery such as Rab GTPases and SNARE proteins, but also shown that alpha-synuclein can be propagated between cells. Here, we discuss the molecular interplay of alpha-synuclein with the intracellular transport machinery, its consequences, and the implications for disease mechanisms.
引用
收藏
页码:693 / 703
页数:11
相关论文
共 50 条
  • [31] Alpha-Synuclein pathology in the enteric nervous system is a potential biomarker for Parkinson's disease
    Emmi, A.
    Sandre, M.
    Russo, F. P.
    Edoardo, S.
    Tombesi, G.
    Garri, F.
    Campagnolo, M.
    Carecchio, M.
    Biundo, R.
    Cosco, G.
    Tushevski, A.
    Macchi, V.
    Porzionato, A.
    De Caro, R.
    Bubacco, L.
    Piero, P.
    Kovacs, G. G.
    Antonini, A.
    BRAIN PATHOLOGY, 2023, 33
  • [32] Alpha-Synuclein induces cofilin pathology: implications on the molecular basis of Parkinson's disease
    Oliveira da Silva, M. I.
    Outeiro, T. F.
    Bamburg, J. R.
    Liz, M. A.
    MOLECULAR BIOLOGY OF THE CELL, 2018, 29 (26) : 345 - 345
  • [33] Parkinson's Disease, Cortical Dysfunction, and Alpha-Synuclein
    Caviness, John N.
    Lue, Lih-Fen
    Beach, Thomas G.
    Hentz, Joseph G.
    Adler, Charles H.
    Sue, Lucia
    Sadeghi, Ramin
    Driver-Dunckley, Erika
    Evidente, Virgilio G.
    Sabbagh, Marwan N.
    Shill, Holly A.
    Walker, Douglas G.
    MOVEMENT DISORDERS, 2011, 26 (08) : 1436 - 1442
  • [34] Targeting Alpha-Synuclein as a Therapy for Parkinson's Disease
    Fields, Carroll Rutherford
    Bengoa-Vergniory, Nora
    Wade-Martins, Richard
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2019, 12
  • [35] Alpha-synuclein and the prion hypothesis in Parkinson's disease
    Melki, R.
    REVUE NEUROLOGIQUE, 2018, 174 (09) : 644 - 652
  • [36] Modeling Parkinson's Disease With the Alpha-Synuclein Protein
    Gomez-Benito, Monica
    Granado, Noelia
    Garcia-Sanz, Patricia
    Michel, Anne
    Dumoulin, Mireille
    Moratalla, Rosario
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [37] Lipids and alpha-synuclein aggregation in Parkinson's disease
    Broersen, K.
    Davletov, B.
    MOVEMENT DISORDERS, 2007, 22 (12) : VI - VI
  • [38] Familial Parkinson's disease - The awakening of alpha-synuclein
    Goedert, M
    NATURE, 1997, 388 (6639) : 232 - 233
  • [39] Sumoylation of alpha-synuclein in the pathogenesis of parkinson's disease
    Engelender, S.
    JOURNAL OF NEUROCHEMISTRY, 2019, 150 : 48 - 48
  • [40] Autoantibodies to alpha-synuclein in inherited Parkinson's disease
    Papachroni, Katerina K.
    Ninkina, Natalia
    Papapanagiotou, Angeliki
    Hadjigeorgiou, Georgios M.
    Xiromerisiou, Georgia
    Papadimitriou, Alexandros
    Kalofoutis, Anastasios
    Buchman, Vladimir L.
    JOURNAL OF NEUROCHEMISTRY, 2007, 101 (03) : 749 - 756